Brain Cancer Trial, Recruiting NCT03861299 Sponsor: Jasper Gerritsen Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT03861299
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 90 years old
  • People whose brain scan (MRI) shows a specific type of brain tumour called Glioblastoma Multiforme, with a particular ring-shaped appearance and signs of dead tissue at the centre, as assessed by the surgeon
  • People whose tumour is located in or near important brain areas that control movement, feeling, or speech, as shown on the MRI
  • People whose tumour is considered suitable for surgery, as determined by a brain surgeon
  • People who are generally in good physical health and able to carry out normal daily activities (scored 80 or above on a medical fitness scale)
  • People who are able to provide written agreement to take part in the trial

Who may not be able to join:

  • People whose tumour is located in the cerebellum, brain stem, or along the middle of the brain
  • People whose scans show tumours appearing in more than one separate area of the brain
  • People whose scans suggest the tumour may have started as a slower-growing (low-grade) brain tumour that has changed over time
  • People who cannot have an MRI scan for medical reasons, such as having a pacemaker
  • People who are unable to give informed consent due to a language barrier or other reason
  • People with a history of psychiatric (mental health) conditions
  • People who have had previous brain tumour surgery
  • People who have previously had a low-grade (slower-growing) brain tumour
  • People who have had a second type of cancer within the past 5 years, except for certain localised skin cancers or cancers confined to one organ that have been fully treated
  • People with severe difficulty speaking or understanding language

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arnaud Vincent, MD PhD, Erasmus Medical Center

Phone: +31629119553

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jasper Gerritsen
Registry
ClinicalTrials.gov
Start date
1 April 2019
Est. completion
1 September 2026

Where this trial is recruiting

🇧🇪 Belgium 🇳🇱 Netherlands

Primary endpoints

Postoperative neurological morbidity; Proportion of gross-total resections

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov